Latest Science News
Astronomers Detect 'RM Flare' Revealing Hidden Companion Star in Fast Radio Burst Source
For the first time, astronomers captured radio signals from a repeating FRB (FRB 220529A) 2.5 billion light-years away, revealing a companion star via a sudden 'RM flare' using China's FAST telescope. This indicates some FRBs originate from binary systems with a magnetar and Sun-like star, reshaping origin theories after 17 months of monitoring.
The findings, published in Science, were led by researchers including Professor Bing Zhang.
FDA Accepts NDA for 177Lu-edotreotide in Neuroendocrine Tumors After Positive Phase 3 Trial
The FDA accepted ITM Radiopharma's New Drug Application for 177Lu-edotreotide to treat somatostatin receptor-positive GEP-NETs, based on Phase 3 COMPETE trial showing superior progression-free survival over everolimus. The drug had fewer adverse events, with a decision expected by August 2026.
This marks progress in targeted radiotherapeutics for neuroendocrine cancers.
Brain Chaperone Protein Funes Enables Amyloid Formation for Long-Term Memory Storage
Stowers Institute researchers discovered chaperone protein Funes in fruit flies that promotes amyloid formation of a memory protein, providing direct evidence amyloids store long-term memories. Fruit flies with more Funes showed enhanced memory, while mutants failed; this challenges views of amyloids as purely harmful.
Findings suggest new drug targets for amyloid diseases by regulating chaperones.
Earth-Sized Exoplanet Candidate HD 137010 b Could Be Colder Than Mars
NASA announced HD 137010 b, an Earth-sized planet transiting a K-dwarf star, potentially colder than frozen Mars, detected via K2 mission. Published January 27, 2026, in The Astrophysical Journal Letters by a team led by Alexander Venner.
This candidate highlights diverse habitable zone worlds.
First Participant Dosed in Phase 1/2 Trial of CRN09682 for SST2-Positive Tumors
A first-in-human trial of CRN09682, targeting SST2-positive neuroendocrine tumors, dosed its first participant, planning up to 150 in dose-escalation and expansion phases. This reflects advancing targeted therapies like radiopharmaceuticals and T-cell engagers for advanced neuroendocrine cancers.
Early phases aim to assess safety and recommended Phase 2 dose.
NASA Awards Texas Tech $5.4M for LISTER Lunar Heat-Flow Probe's Third Mission
NASA granted Texas Tech University $5.4 million for LISTER 3, the third lunar heat-flow probe mission following successful LISTER 1 on Blue Ghost Mission 1. LISTER drills to measure subsurface temperature and conductivity, reaching three feet deep in prior tests.
Geophysicist Seiichi Nagihara's 15-year project advances Moon interior understanding.
Doomsday Clock Set to 85 Seconds to Midnight in 2026 Update
Scientists adjusted the Doomsday Clock to 85 seconds to midnight, the closest ever, signaling heightened global risks from nuclear, climate, and tech threats. Announced Tuesday by the Bulletin of Atomic Scientists at University of Chicago.
Midnight represents uninhabitable Earth conditions.
New GWAS Identifies 49 Migraine Loci and 283 Associated Genes
A genome-wide study found 49 significant migraine loci, 36 novel, mapping to 283 genes including MAML3 (chronic pain) and TLR4 (neuroinflammation). Results build on prior studies with replications and highlight pathways for new therapies.
Presented in January 2026 migraine research update.
Spatial Omics and AI to End Diagnostic Odyssey for Inflammatory Diseases
WEHI researchers use 3D tissue mapping, AI, and spatial omics to create cell atlases, speeding diagnosis of chronic inflammatory diseases via biopsy analysis. Aims to integrate into standard tests, analyzing billions of cells across genes for precision medicine.
Vision includes digital pathology statewide in Victoria.
TRIUMPH Study Confirms CGRP Therapies' Real-World Effectiveness for Migraine
Phase 4 TRIUMPH trial showed CGRP-targeted preventives superior to traditional migraine treatments in real-world settings. International observational study compared classes amid limited prior direct data.
Highlights transformation in migraine care.
Warning: Common CGRP Detection Kit Fails to Identify Bioactive Isoforms
Researchers found Kit A, widely used for CGRP in headache studies, cannot detect mature α- or β-CGRP isoforms, invalidating prior clinical conclusions. Kit B reliably detected them; implications demand field-wide review.
Reported in January 2026 migraine update.
Nanofoam in Pollen Inspires Efficient, Cheaper EV Batteries
Natural History Museum scientists discovered pollen nanofoam structures that could enhance electric car batteries' efficiency and cost. Mimicking these may power vehicles and save lives via better energy storage.
Part of recent science news highlights.